A MATCHED COMPARISON OF TISAGENLECLEUCEL AND AXICABTAGENE CILOLEUCEL CAR T CELLS IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-LIFE LYSA STUDY FROM THE FRENCH DESCAR-T REGISTRY

CAR T- CELLS ASSOCIATED ACUTE TOXICITY IN B-CELL NON-HODGKIN LYMPHOMA: REAL-WORLD STUDY FROM THE DESCAR-T REGISTRY

Retour d’expérience après 2 années de fonctionnement du registre DESCAR-T

First results of DLBCL patients treated with CAR-T cells and enrolled in DESCAR-T registry, The French real-life database for CAR-T cells in hematologic malignancies

Abstract

First results of DLBCL patients treated with CAR-T cells and enrolled in DESCAR-T registry, a French real-life database for CAR-T cells in hematologic malignancies

ICMLugano Steven Le Gouill Abstract N°084

Résultats de la cohorte lymphomes B diffus à grandes cellules traités par CAR-T du registre DESCAR-T (vie réelle)

Outcome of Relapsed/Refractory Aggressive B-Cell Lymphoma Patients Relapsing after Anti-CD19 CAR T-Cells and Enrolled in the Descar-T French National Registry
Blood | American Society of Hematology (ashpublications.org)

A Propensity Score-Matched Comparison of Axi-Cel and Tisa-Cel for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Real-Life: A Lysa Study from the Descar-T Registry
Blood | American Society of Hematology (ashpublications.org)

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a “Real-Life” Study from the Descar-T Registry and Lysa Group
Blood | American Society of Hematology (ashpublications.org)

First results of DLBCL patients treated with CAR-T cells and enrolled in DESCAR-T registry, a French real-life database for CAR-T cells in hematologic malignancies